BioSpace News Archive

Puma Biotechnology, Inc., a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at the 39th Annual J.P. Morgan Healthcare Conference, which will be held virtually. Puma’s presentation will take place at 7:50 a.m. PST on Thursday, January 14, 2021.

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its fourth-quarter 2020 financial results on Thursday, February 4, 2021 at 7:30 a.m. Central Time

Medpace Holdings, Inc. announced that it will report its fourth quarter and fiscal year 2020 financial results after the market close on Monday, February 15, 2021.

Impulse Dynamics, a company dedicated to helping healthcare providers improve the lives of people with heart failure, today announced the first patient in Brazil was treated with its innovative CCM® therapy delivered by the Optimizer® system.

Qpex Biopharma, Inc. (Qpex), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative anti-infective therapies, announced the appointment of Paul Westberg as chief business officer

BioAge Labs, Inc., is scheduled to present virtually at the 39th Annual J.P. Morgan Healthcare Conference (JPM) on Tuesday, January 12, 2021 at 2:00pm ET. The BioAge leadership team also will be available for one-on-one meetings via BIO Partnering @ JPM from January 11-15, 2021. Kristen Fortney, BioAge’s chief executive officer, will provide an overview of BioAge’s systems biology and data-driven platform to map the

PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing regenerative tissue products and biomaterials, announced today that it will present at the H.C. Wainwright Virtual Bioconnect Conference on January 11, 2021. A webcast of the presentation will be available on January 11, 2021 beginning at 6:00 a.m. Eastern Time and can be accessed in the “News & Media/Events” section of PolarityTE’s website at www

MBX Biosciences, a drug discovery company focused on rare endocrine diseases, today announced the appointment of Mary Jane Geiger, M.D., Ph.D., FACP, FAHA, to the newly created role of chief medical officer.

Xenetic Biosciences, Inc. announced today that Jeffrey Eisenberg, Chief Executive Officer of Xenetic will present in a fireside chat at the H.C. Wainwright BioConnect 2021 Virtual Conference taking place January 11-

Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) today announced that the Company has entered into definitive agreements with Endo Ventures Limited, a subsidiary of Endo International plc (“Endo”) (NASDAQ: ENDP), to register, commercialize, and distribute abaloparatide on an exclusive basis in Canada